Why the study?
Unresolved issues remain regarding treatment tactics, procedure choice, and patient selection for surgery in AF associated with valvular heart disease, prompting study into the influence of miRNAs.
What is the influence of miRNAs on the development and course of atrial fibrillation in patients with valvular heart disease?
What is the influence of miRNAs on the development and course of atrial fibrillation in patients with valvular heart disease?
This review highlights the potential role of miRNAs in understanding the development and management of atrial fibrillation in patients undergoing surgery for valvular heart disease.
Answers are grounded in this paper and cite their sources.
miRNAs may modulate AF in valvular disease; hypothesis-generating and should not yet change practice.
Atrial fibrillation (AF) is a common type of arrhythmia that is frequently observed in clinical practice. In patients admitted to the cardiac surgery department, AF most often develops due to valvular heart disease, as well as in the postoperative period. Modern surgical techniques for valvular defects make it possible to get rid of AF. However, there are still unresolved issues of treatment tactics, the selection of procedure and the correct selection of patients for surgery. In order to find answers to these questions, the influence of microribonucleic acids (miRNAs) on the development and course of AF is being studied. The article presents an analytical review on the influence of miRNA on the occurrence, regulation and course of AF in patients with valvular heart disease before surgery and in the postoperative period.
No takes yet. Share an insight, caveat, or question.
Abdulyanov et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: